India Lifts Export Ban on Remdesivir and Its Component API
India's Directorate General of Foreign Trade moved its export policy for COVID-19 treatment drug remdesivir and its active pharmaceutical ingredient from “prohibited” to “restricted” in a June 14 notification. The export of the drug or its API against the drug's…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
advance authorizations will no longer need a separate authorization, the release said.